Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Identification of novel antigens that protect against systemic meningococcal infection.

Sun Y, Li Y, Exley RM, Winterbotham M, Ison C, Smith H, Tang CM.

Vaccine. 2005 Jul 14;23(32):4136-41.

PMID:
15964482
2.
4.

Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.

Delgado M, Yero D, Niebla O, González S, Climent Y, Pérez Y, Cobas K, Caballero E, García D, Pajón R.

Vaccine. 2007 Dec 5;25(50):8420-31.

PMID:
17996338
5.
6.

Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.

Jessouroun E, da Silveira IF, Larangeira AP, Pereira S, Fernandes SA, Rabinovitch L, Frasch CE, Castro-Faria-Neto HC, Bozza PT.

Vaccine. 2004 Jun 30;22(20):2617-25.

PMID:
15193387
7.

Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection.

West D, Reddin K, Matheson M, Heath R, Funnell S, Hudson M, Robinson A, Gorringe A.

Infect Immun. 2001 Mar;69(3):1561-7.

8.

Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.

Li Y, Zhang Q, Winterbotham M, Mowe E, Gorringe A, Tang CM.

Infect Immun. 2006 Nov;74(11):6348-55.

9.

Meningococcal disease: a review on available vaccines and vaccines in development.

Bröker M, Fantoni S.

Minerva Med. 2007 Oct;98(5):575-89. Review.

PMID:
18043565
10.

Recent developments in vaccines to prevent meningococcal serogroup B infections.

Vermont CL, van den Dobbelsteen GP, de Groot R.

Curr Opin Mol Ther. 2003 Feb;5(1):33-8. Review.

PMID:
12669468
11.

Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

Finney M, Vaughan T, Taylor S, Hudson MJ, Pratt C, Wheeler JX, Vipond C, Feavers I, Jones C, Findlow J, Borrow R, Gorringe A.

Hum Vaccin. 2008 Jan-Feb;4(1):23-30.

PMID:
17921703
12.

Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B.

Yero D, Pajón R, Pérez Y, Fariñas M, Cobas K, Diaz D, Solis RL, Acosta A, Brookes C, Taylor S, Gorringe A.

Vaccine. 2007 Jul 9;25(28):5175-88.

PMID:
17544180
13.

Meningococcal vaccines.

Rosenstein NE, Fischer M, Tappero JW.

Infect Dis Clin North Am. 2001 Mar;15(1):155-69. Review.

PMID:
11301813
14.

Serogroup B meningococcal vaccines.

Zimmer SM, Stephens DS.

Curr Opin Investig Drugs. 2006 Aug;7(8):733-9. Review.

PMID:
16955685
15.

A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.

Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS.

Pediatr Infect Dis J. 2013 Oct;32(10):1096-101. doi: 10.1097/INF.0b013e31829aa63b.

PMID:
23694830
16.

Assessment of vaccine potential of the Neisseria-specific protein NMB0938.

Sardiñas G, Climent Y, Rodríguez Y, González S, García D, Cobas K, Caballero E, Pérez Y, Brookes C, Taylor S, Gorringe A, Delgado M, Pajón R, Yero D.

Vaccine. 2009 Nov 16;27(49):6910-7. doi: 10.1016/j.vaccine.2009.09.005.

PMID:
19751688
17.

Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?

Gorringe AR.

Expert Rev Vaccines. 2005 Jun;4(3):373-9. Review.

PMID:
16026250
18.

The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

Gorringe A, Halliwell D, Matheson M, Reddin K, Finney M, Hudson M.

Vaccine. 2005 Mar 18;23(17-18):2210-3.

PMID:
15755597
19.

Quest for a broad-range vaccine against Neisseria meningitidis serogroup B: implications of genetic variations of the surface-exposed proteins.

de Filippis I.

J Med Microbiol. 2009 Sep;58(Pt 9):1127-32. doi: 10.1099/jmm.0.011189-0. Review.

PMID:
19528146
20.

Prevention of group B meningococcal disease by vaccination: a difficult task.

Thomas M.

N Z Med J. 2004 Aug 20;117(1200):U1016.

PMID:
15475986

Supplemental Content

Support Center